Immunity, inflammation and cancer
PRINCIPAL INVESTIGATORS
Sonia-Vanina Forcales Fernández
Juan José Rojas Expósito
Joan Manils Pacheco
Juan José Rojas Expósito
Joan Manils Pacheco
POSTDOCTORAL RESEARCHERS
- Joan Martorell Ribera
- Cristina Moreta Moraleda
- Alejandra Gadea Solidoro
PREDOCTORAL RESEARCHERS
- Francisco Javier Navas López
- Ana Del Cañizo Lazaro
- Daniel López Ramajo
- Ingrid Filgaira Enri
- Maria Martin Agramunt
- Miquel Conesa Torrandell
- Carmen Bueno Merino
- Shi Lejuan
Cancer
Oncobell
Scientific production
5
PAPERS
Average IF: 6,12
2
LED PAPER
Average IF: 7,85
1 PUBLICATION IN FIRST DECILE
4 PUBLICATIONS IN FIRST QUARTILE
5 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Riederer,S;del Canizo,A;Navas,J;Peter,MG;Link,EK;Sutter,G;Rojas,JJ, Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease, Cancer Gene Ther., 2023;30(7):1029-1039, doi:10.1038/s41417-023-00610-5
- Moreta Moraleda,C;Queralt,C;Vendrell Ayats,C;Forcales,S;Martínez Balibrea,E, Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?, Pharmacol. Res., 2023;196106924-106924, doi:10.1016/j.phrs.2023.106924
- Zoroddu,S;Sanna,L;Bordoni,V;Lyu,WD;Murineddu,G;Pinna,GA;Forcales,SV et al, RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines, Int. J. Mol. Sci., 2023;24(14):doi:10.3390/ijms241411263
- Llorente,X;Esteruelas,G;Bonilla,L;Agudelo,MG;Filgaira,I;Lopez Ramajo,D;Gong,RC et al, Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases, Int. J. Mol. Sci., 2023;24(9):doi:10.3390/ijms24098053
- Langenmayer,MC;Luelf Averhoff,AT;Marr,L;Jany,S;Freudenstein,A;Adam Neumair,S;Tscherne,A et al, Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice, Pathogens, 2023;12(7):doi:10.3390/pathogens12070867
Research highlights
PROJECTS
1 Ongoing competitive project
INNOVATION
1 Patent
NETWORKS
RICORS -TERAV
Selected projects
- AEC22003. Towards a viral immunotherapy able to generate robust antitumor immune responses. AECC. Budget: 215.071,91€. 2022-2025. PI: Juan José Rojas Expósito.